Current multidisciplinary oncology series

gan Sebio, Ana, Lenz, Heinz-Josef
Cyhoeddwyd 2014

Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor

gan Sebio, Ana, Lenz, Heinz-Josef
Cyhoeddwyd yn Clin Cancer Res (2015)

Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan‐induced severe toxicity

gan Riera, Pau, Salazar, Juliana, Virgili, Anna C., Tobeña, María, Sebio, Ana, Gallano, Pía, Barnadas, Agustí, Páez, David
Cyhoeddwyd yn Br J Clin Pharmacol (2018)

ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients

gan Riera, Pau, Artigas-Baleri, Alícia, Salazar, Juliana, Sebio, Ana, Virgili, Anna C., Arranz, María Jesús, Páez, David
Cyhoeddwyd yn Front Pharmacol (2020)

Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients ac...

gan Páez, David, Tobeña, María, Fernández-Plana, Julen, Sebio, Ana, Virgili, Anna C., Cirera, Lluís, Barnadas, Agustí, Riera, Pau, Sullivan, Ivana, Salazar, Juliana
Cyhoeddwyd yn Br J Cancer (2018)

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs

gan Nogales, Vanesa, Reinhold, William C., Varma, Sudhir, Martinez-Cardus, Anna, Moutinho, Catia, Moran, Sebastian, Heyn, Holger, Sebio, Ana, Barnadas, Agusti, Pommier, Yves, Esteller, Manel
Cyhoeddwyd yn Oncotarget (2015)

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer

gan Sebio, Ana, Matsusaka, Satoshi, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stremitzer, Stefan, Stintzing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Cyhoeddwyd yn Pharmacogenomics J (2015)

Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer

gan Sebio, Ana, Gerger, Armin, Matsusaka, Satoshi, Yang, Dongyun, Zhang, Wu, Stremitzer, Stefan, Stintizing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Ning, Yan, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Cyhoeddwyd yn Pharmacogenet Genomics (2015)

Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients

gan Riera, Pau, Rodríguez-Santiago, Benjamín, Lasa, Adriana, Gonzalez-Quereda, Lidia, Martín, Berta, Salazar, Juliana, Sebio, Ana, Virgili, Anna C., Minguillón, Jordi, Camps, Cristina, Surrallés, Jordi, Páez, David
Cyhoeddwyd yn Cancers (Basel) (2020)

Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases

gan Stremitzer, Stefan, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stintzing, Sebastian, Sebio, Ana, Sunakawa, Yu, Yamauchi, Shinichi, Matsusaka, Satoshi, El-Khoueiry, Rita, Stift, Judith, Wrba, Friedrich, Gruenberger, Thomas, Lenz, Heinz-Josef
Cyhoeddwyd yn Cancer (2015)

A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report

gan Moura, David S., Díaz-Martín, Juan, Bagué, Silvia, Orellana-Fernandez, Ruth, Sebio, Ana, Mondaza-Hernandez, Jose L., Salguero-Aranda, Carmen, Rojo, Federico, Hindi, Nadia, Fletcher, Christopher D. M., Martin-Broto, Javier
Cyhoeddwyd yn Int J Mol Sci (2021)

TWIST1 polymorphisms predict survival in patients with metastatic colorectal cancer receiving first-line bevacizumab plus oxaliplatin-based chemotherapy

gan Matsusaka, Satoshi, Zhang, Wu, Cao, Shu, Hanna, Diana L., Sunakawa, Yu, Sebio, Ana, Ueno, Masashi, Yang, Dongyun, Ning, Yan, Parekh, Anish, Okazaki, Satoshi, Berger, Martin D., Ichikawa, Wataru, Mizunuma, Nobuyuki, Lenz, Heinz-Josef.
Cyhoeddwyd yn Mol Cancer Ther (2016)

Prognostic impact of c-MET polymorphism on clinical outcome in loco-regional gastric cancer patients

gan Sunakawa, Yu, Wakatsuki, Takeru, Yang, Dongyun, Zhang, Wu, Ning, Yan, Stintzing, Sebastian, Stremitzer, Stefan, Yamauchi, Shinichi, Sebio, Ana, El-khoueiry, Rita, Iqbal, Syma, Afsaneh, Barzi, Gerger, Armin, Stotz, Michael, Azuma, Mizutomo, Watanabe, Masahiko, Koizumi, Wasaburo, Lenz, Heinz-Josef
Cyhoeddwyd yn Pharmacogenet Genomics (2014)

Polymorphisms in genes involved in EGFR-turnover are predictive for cetuximab efficacy in colorectal cancer

gan Stintzing, Sebastian, Zhang, Wu, Heinemann, Volker, Neureiter, Daniel, Kemmerling, Ralf, Kirchner, Thomas, Jung, Andreas, Folwaczny, Matthias, Yang, Dongyun, Ning, Yan, Sebio, Ana, Stremitzer, Stefan, Sunakawa, Yu, Matsusaka, Satoshi, Yamauchi, Shinichi, Loupakis, Fotios, Cremolini, Chiara, Falcone, Alfredo, Lenz, Heinz-Josef
Cyhoeddwyd yn Mol Cancer Ther (2015)

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors

gan Serrano, César, Vivancos, Ana, López-Pousa, Antonio, Matito, Judit, Mancuso, Francesco M., Valverde, Claudia, Quiroga, Sergi, Landolfi, Stefania, Castro, Sandra, Dopazo, Cristina, Sebio, Ana, Virgili, Anna C., Menso, María M., Martín-Broto, Javier, Sansó, Miriam, García-Valverde, Alfonso, Rosell, Jordi, Fletcher, Jonathan A., George, Suzanne, Carles, Joan, Arribas, Joaquín
Cyhoeddwyd yn BMC Cancer (2020)

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib

gan Serrano, César, García‐del‐Muro, Xavier, Valverde, Claudia, Sebio, Ana, Durán, José, Manzano, Aránzazu, Pajares, Isabel, Hindi, Nadia, Landolfi, Stefania, Jiménez, Laura, Rubió‐Casadevall, Jordi, Estival, Anna, Lavernia, Javier, Safont, María José, Pericay, Carles, Díaz‐Beveridge, Roberto, Martínez‐Marín, Virginia, Vicente‐Baz, David, Vivancos, Ana, Hernández‐Losa, Javier, Arribas, Joaquín, Carles, Joan
Cyhoeddwyd yn Oncologist (2018)